Impact of Dual Antiplatelet Therapy with Proton Pump Inhibitors on the Outcome of Patients with Acute Coronary Syndrome Undergoing Drug-Eluting Stent Implantation

Table 5

Logistic regression analysis, independent correlates of acute coronary syndrome (ACS) and of target vessel revascularization (TVR).

Variability	Coefficient	Std. error	𝑃 value	OR	95% CI
re-ACS
Omeprazole	1.6113	0.4059	0.0001	5.0093	2.2606–11.1002
Esomeprazole	1.9588	0.6198	0.0016	7.09	2.1042–23.8046
Diabetes	0.8646	0.3851	0.0248	2.37	1.1159–5.0502
TVR
Omeprazole	1.0629	0.4222	0.0118	2.8947	1.2654–6.6222

re-ACS: rehospitalization for acute coronary syndrome; TVR: target vessel revascularization.